Ifm Investors Pty LTD Novavax Inc Transaction History

Ifm Investors Pty LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$36.28 - $75.29 $402,562 - $835,417	-11,096 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$69.73 - $142.9 $126,838 - $259,935	1,819 Added 19.61%	11,096 $817,000
Q4 2021 Jan 18, 2022	SELL	$134.56 - $217.97 $23,548 - $38,144	-175 Reduced 1.85%	9,277 $1.33 Million
Q2 2021 Jul 16, 2021	BUY	$121.0 - $257.67 $1.14 Million - $2.44 Million	9,452 New	9,452 $2.01 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ifm Investors Pty LTD with notifications on news.